Viewing Study NCT02203032


Ignite Creation Date: 2025-12-24 @ 9:28 PM
Ignite Modification Date: 2026-01-20 @ 11:35 AM
Study NCT ID: NCT02203032
Status: COMPLETED
Last Update Posted: 2017-09-12
First Post: 2014-07-25
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: A Study of Guselkumab in Participants With Moderate to Severe Plaque-type Psoriasis and an Inadequate Response to Ustekinumab
Sponsor:
Organization: